Close
Digital Health & Ai Innovation summit 2026
LiGHT26

Nu Skin Enterprises Increases Stock Repurchase Authorization

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Saint Peterโ€™s Healthcare System Advances Patient...

Saint Peter's Healthcare System in New Brunswick, NJ, has...

Artivion Receives FDA Approval for AMDS...

Artivion has secured FDA premarket approval (PMA) for its...

Getinge Opens Digital OR Hub to...

Getinge has expanded its investment in digital healthcare by...
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that its board of directors has increased its stock repurchase authorization to $500 million, an increase of approximately $260 million. 
"We remain confident in our ability to grow the business as we begin to introduce our innovative new ageLOC products," said Ritch Wood, chief financial officer. "We plan to use our financial strength to repurchase shares and create shareholder value."

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Artivion Receives FDA Approval for AMDS Hybrid Prosthesis

Artivion has secured FDA premarket approval (PMA) for its...

Getinge Opens Digital OR Hub to Advance Surgical Software

Getinge has expanded its investment in digital healthcare by...

Prosus Announces โ‚ฌ400 Million Investment in AI-Native Healthcare Platform Alan

Prosus has officially announced a โ‚ฌ400 million (US$460 million)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป